Jurox adds 5ml vial size to anaesthesia portfolio

In an aim to give more flexibility for people in the veterinary industry while producing less waste, Jurox has expanded its product portfolio with a 5ml vial size to its Methadyne product (usually 10mg/ml).

Methadone, a drug similar but less sedative than morphine, is the active component for Methadyne. This is a solution used for injections in Jurox’s “extensive anaesthesia and analgesia portfolio.”

The purpose of the product is to be dispensed for angalgesia of tolerable to serious discomfort in cats and dogs. It provides neuroleptanalgesia alongside a neuroleptic drug used before general anaesthesia.

The company claims that Methadyne has demonstrated compatibility with the syringe tool that is used for various other injection solutions that are made up of acepromazine, medetomidine and dexmedetomidine. The Methadyne is reactive to light which means it has to be presented inside an amber coloured container.

Senior veterinary technical advisor at Jurox, Dan Cripwell, said that he is “delighted that Jurox can provide the UK veterinary market with this evolution in our multidose methadone formulation, which is now available in both 5ml and 10ml vials. We constantly strive to provide the veterinary profession with first class clinical and technical support, and in this instance we were able to assess what improvements could be made to our existing drug portfolio and respond to the profession’s feedback to help reduce wastage of controlled drugs when they are needed in smaller volume. Our hope is that, as well as the recent mixing claims added to the product licence, the new vial size will encourage the best clinical use and make Methadyne 10mg/ml more accessible.”